{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:54:13Z","timestamp":1791032053374,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Widespread mammography screening has resulted in a significant decline in breast cancer deaths, but it is resource intensive. The WISDOM (Women Informed to Screen Depending on Measures of Risk) trial attempts to assess screening based on individual risk as an alternative to age-based screening (annual screening starting at age 40 years). In their initial report, the authors concluded that risk-based screening is safe and acceptable. Their results do not support this conclusion. The first primary endpoint to test the noninferiority of risk-based screening used the metric of stage IIB and higher breast cancers. Many of these cancers would be apparent on physical exam, thus eliminating some advantages of early detection and ignoring shortcomings of the risk-based approach. In addition, the study set an extremely weak noninferiority margin, compromising their conclusion concerning noninferiority. Details of mammography and MRI use in WISDOM reflect poor compliance with screening protocols in both arms of the study. Substantial non-compliance as well as out-of-study imaging in both cohorts resulted in two nearly identical protocols, rather than a comparison of different screening strategies. The study\u2019s findings of substantial non-compliance to the risk-based protocol make it difficult to justify risk-based screening being acceptable to women. The trial\u2019s second primary endpoint, to test whether risk-based screening yielded fewer biopsies than annual screening, failed. The risk-based screening protocol is labor intensive and would be challenging to implement in the typical primary care practice. The vast majority of breast cancers occur in average-risk women and could be missed in a risk-based system, especially in women under age 50 and minority women.<\/jats:p>","DOI":"10.1093\/jbi\/wbag048","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:32:31Z","timestamp":1784993551000},"page":"471-476","source":"Crossref","is-referenced-by-count":0,"title":["Is Risk-based Screening Justified by the WISDOM Trial?"],"prefix":"10.1093","volume":"8","author":[{"given":"Debra L","family":"Monticciolo","sequence":"first","affiliation":[{"name":"Scott & White Clinic, BSW Central Texas , Temple, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9971-2651","authenticated-orcid":false,"given":"R Edward","family":"Hendrick","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Colorado Anschutz School of Medicine , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"11","key":"2026100308213512900_wbag048-B1","doi-asserted-by":"publisher","first-page":"dju261","DOI":"10.1093\/jnci\/dju261","article-title":"Pan-Canadian study of mammography screening and mortality from breast cancer","volume":"106","author":"Coldman","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"2026100308213512900_wbag048-B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1258\/jms.2012.012078","article-title":"The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies","volume":"19","author":"Broeders","year":"2012","journal-title":"J Med Screen"},{"issue":"9","key":"2026100308213512900_wbag048-B3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1158\/1055-9965.EPI-12-0468","article-title":"Mammographic screening and breast cancer mortality: a case-control study and meta-analysis","volume":"21","author":"Nickson","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2026100308213512900_wbag048-B4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jbi\/wbaf007","article-title":"Recent trends in breast cancer mortality rates for U.S. women by age and race\/ethnicity","volume":"7","author":"Monticciolo","year":"2025","journal-title":"J Breast Imaging"},{"issue":"4","key":"2026100308213512900_wbag048-B5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cncr.31840","article-title":"The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening","volume":"125","author":"Tabar","year":"2019","journal-title":"Cancer"},{"issue":"13","key":"2026100308213512900_wbag048-B6","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.32859","article-title":"Mammography screening reduces rates of advanced and fatal cancers: results in 549,091 women","volume":"126","author":"Duffy","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"2026100308213512900_wbag048-B7","doi-asserted-by":"publisher","first-page":"e232658","DOI":"10.1148\/radiol.232658","article-title":"Outcomes of breast cancer screening strategies based on Cancer Intervention and Surveillance Modeling Network estimates","volume":"310","author":"Monticciolo","year":"2024","journal-title":"Radiology"},{"key":"2026100308213512900_wbag048-B8","author":"Trentham-Dietz"},{"key":"2026100308213512900_wbag048-B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","article-title":"The WISDOM study: breaking the deadlock in the breast cancer screening debate","volume":"3","author":"Esserman","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"2026100308213512900_wbag048-B10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12885-025-13848-z","article-title":"Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study","volume":"25","author":"Roux","year":"2025","journal-title":"BMC Cancer"},{"issue":"9","key":"2026100308213512900_wbag048-B11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jacr.2023.04.002","article-title":"Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR","volume":"20","author":"Monticciolo","year":"2023","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"2026100308213512900_wbag048-B12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jama.2025.24784","article-title":"Risk-based vs annual breast cancer screening: the WISDOM randomized clinical trial","volume":"335","author":"Esserman","year":"2026","journal-title":"JAMA"},{"issue":"3","key":"2026100308213512900_wbag048-B13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-020-06020-7","article-title":"The WISDOM trial is based on faulty reasoning and has major design and execution problems","volume":"185","author":"Kopans","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2026100308213512900_wbag048-B14","article-title":"ACR withdraws from WISDOM breast cancer screening trial","volume":"30","author":"American College of Radiology.","year":"2019","journal-title":"Updated October"},{"key":"2026100308213512900_wbag048-B15","doi-asserted-by":"publisher","first-page":"h4901","DOI":"10.1136\/bmj.h4901","article-title":"Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients","volume":"351","author":"Saadatmand","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"2026100308213512900_wbag048-B16","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1016\/j.annonc.2022.03.152","article-title":"135P Real-time genotyping-based breast cancer risk assessment in MyPeBS, an international randomized trial in the general population comparing risk-stratified to standard breast cancer screening (BCS)","volume":"33","author":"Delaloge","year":"2022","journal-title":"Annals of Oncology"},{"issue":"4-5","key":"2026100308213512900_wbag048-B17","first-page":"317","article-title":"Tailored breast screening trial (TBST)","volume":"37","author":"Paci","year":"2013","journal-title":"Epidemiol Prev"},{"key":"2026100308213512900_wbag048-B18","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1245\/s10434-020-09426-1","article-title":"Personalized screening for breast cancer: rationale, present practices, and future directions","volume":"28","author":"Allweis","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"2026100308213512900_wbag048-B19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jama.2025.24817","article-title":"Unlocking the potential of risk-based screening for breast cancer form detection to prevention","volume":"335","author":"Baxter","year":"2026","journal-title":"JAMA"},{"issue":"2","key":"2026100308213512900_wbag048-B20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jacr.2019.09.008","article-title":"Preventive care: how mammography utilization changes as women age","volume":"17","author":"Yuan","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"2026100308213512900_wbag048-B21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jacr.2019.01.028","article-title":"Breast screening utilization and cost sharing among employed insured women after the affordable care act","volume":"16","author":"Carlos","year":"2019","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"2026100308213512900_wbag048-B22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/1475-6773.12486","article-title":"Screening mammography for free: impact of eliminating cost sharing on cancer screening rates","volume":"52","author":"Jena","year":"2017","journal-title":"Health Serv Res"},{"issue":"5","key":"2026100308213512900_wbag048-B23","doi-asserted-by":"publisher","first-page":"djw290","DOI":"10.1093\/jnci\/djw290","article-title":"Athena Breast Health Network Investigators. Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial","volume":"109","author":"Shieh","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"659","key":"2026100308213512900_wbag048-B24","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.3399\/bjgp17X689377","article-title":"Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs\u2019 attitudes","volume":"67","author":"Smith","year":"2017","journal-title":"Br J Gen Pract"},{"issue":"33","key":"2026100308213512900_wbag048-B25","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J Clin Oncol"},{"issue":"23","key":"2026100308213512900_wbag048-B26","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1002\/cncr.33846","article-title":"Age distributions of breast cancer diagnosis and mortality by race and ethnicity in United States women","volume":"127","author":"Hendrick","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"2026100308213512900_wbag048-B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"},{"key":"2026100308213512900_wbag048-B28","volume-title":"Saving Women\u2019s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis","author":"Joy","year":"2005"}],"container-title":["Journal of Breast Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/8\/5\/471\/70032360\/wbag048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/8\/5\/471\/70032360\/wbag048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:21:49Z","timestamp":1791030109000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbi\/article\/8\/5\/471\/8741885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7,25]]},"published-print":{"date-parts":[[2026,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbi\/wbag048","relation":{},"ISSN":["2631-6110","2631-6129"],"issn-type":[{"value":"2631-6110","type":"print"},{"value":"2631-6129","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,25]]}}}